According to the MESNA registry, what are the recommendations for elective surgical repair and imaging surveillance of aortic root dilation based on diameter, growth rate, family history, and connective‑tissue disorder?

MESNA Registry Recommendations for Aortic Root Dilation Management

I need to clarify an important point: There is no "MESNA registry" for aortic disease. You may be thinking of the ACC/AHA guidelines or other major cardiovascular registries. MESNA is actually a medication (2-mercaptoethane sulfonate sodium) used to prevent hemorrhagic cystitis from chemotherapy agents like cyclophosphamide and ifosfamide—it has nothing to do with aortic disease management.

However, I'll provide you with the current evidence-based recommendations for elective surgical repair and imaging surveillance of aortic root dilation based on the major cardiovascular guidelines:

Surgical Intervention Thresholds

For Bicuspid Aortic Valve (BAV) Patients

Surgery is definitively recommended at ≥5.5 cm aortic root or ascending aorta diameter 1. This is the primary threshold regardless of valve morphology.

Earlier intervention at 5.0-5.4 cm is reasonable when additional risk factors are present 1:

• Family history of aortic dissection
• Rapid growth ≥0.3 cm/year (confirmed over consecutive measurements)
• Aortic coarctation
• Root phenotype (10-20% of BAV patients with more rapid growth)
• Cross-sectional area to height ratio ≥10 cm²/m

Concomitant aortic repair at ≥4.5 cm is reasonable when already undergoing valve surgery for stenosis or regurgitation, particularly in younger patients with long life expectancy 1.

For Marfan Syndrome

Surgery is indicated at ≥5.0 cm aortic root diameter 1, 2. This lower threshold compared to BAV reflects the higher dissection risk in connective tissue disorders.

Earlier intervention at <5.0 cm is reasonable with high-risk features 1:

• Rapid growth ≥0.3 cm/year
• Family history of aortic dissection
• Desire for pregnancy
• Cross-sectional area to height ratio ≥10 cm²/m
• Severe aortic regurgitation

For women with Marfan syndrome desiring pregnancy, prophylactic surgery is recommended at >4.5 cm 2.

For Other Connective Tissue Disorders

Loeys-Dietz syndrome and related disorders warrant even more aggressive thresholds, though specific diameter cutoffs require individualized assessment based on genetic subtype and family history 1, 2.

Imaging Surveillance Protocols

Bicuspid Aortic Valve

• Initial TTE at diagnosis to establish baseline measurements 2
• Annual TTE when diameter >4.0 cm 2
• Every 6-12 months when diameter ≥4.5 cm 1
• CT or MRI when diameter exceeds 4.5 cm or when significant measurement discrepancies exist between TTE studies 2

Marfan Syndrome

• Baseline TTE, then repeat at 6 months to establish growth rate 2
• Annual TTE if stable 2
• Every 6-12 months when diameter ≥4.5 cm, with frequency determined by presence of additional risk factors 2
• Baseline CT/MRI from head to pelvis to evaluate entire aorta 1, 2
• Annual CT/MRI surveillance if any segment is dilated or dissected 1
• Every 3 years CT/MRI if only root/ascending aorta involved and stable 2

Loeys-Dietz Syndrome

• TTE every 6-12 months depending on diameter and growth 1, 2
• Baseline CT/MRI head to pelvis 1
• CT/MRI surveillance every 1-3 years for entire aorta and branch vessels 2
• Cerebral aneurysm screening every 2-3 years with MRI or CT 1

Critical Growth Rate Thresholds

Confirmed growth of ≥0.5 cm in 1 year is an absolute indication for surgery 1.

Sustained growth of ≥0.3 cm/year over 2 consecutive years also warrants intervention 1, as this substantially exceeds expected growth rates (typically <0.5 mm/year in non-syndromic patients) 1, 3.

Important Caveats

Measurement technique matters critically: Growth rates are most accurate when assessed using cardiac-gated CT or MRI with centerline measurement techniques 1. Comparing different imaging modalities or contrast vs. non-contrast studies introduces significant error.

The aortic root is more dangerous than the ascending aorta: Recent data suggests root dilation carries higher dissection risk than mid-ascending dilation, with hinge points at 5.0 cm for root vs. 5.25 cm for mid-ascending aorta 4. This supports more aggressive intervention for root phenotype.

Height indexing improves risk stratification: Cross-sectional area (cm²) to height (m) ratio ≥10 cm²/m predicts better outcomes with prophylactic surgery 1.

All interventions should be performed by experienced surgeons in Multidisciplinary Aortic Teams to achieve the low operative mortality (<2-3%) that justifies prophylactic surgery 1.